Mina Sedrak: Why Protected Time Remains One of the Greatest Challenges Facing Clinical Trialists
Mina S. Sedrak/stemcell.ucla.edu

Mina Sedrak: Why Protected Time Remains One of the Greatest Challenges Facing Clinical Trialists

Mina Sedrak, Director of Cancer and Aging Program and Associate Professor of Medicine at UCLA,, shared a post on X:

‘I need more protected time.’

Our ACS Journal Cancer commentary explores why protected time remains one of the greatest challenges facing clinical trialists in oncology.

Honored to write this with Suresh S. Ramalingam,  Joseph A. Sparano

Title: “Protected time” for clinical investigators in medical oncology: The persistent gap between expectation and reality

Authors: Mina S. Sedrak, Suresh S. Ramalingam,  Joseph A. Sparano

Read the Article

Mina Sedrak

Other articles featuring Mina Sedrak on OncoDaily.